cancer therapeutics Market Research Reports

Titlepublishedprice

Global Pancreatic Cancer Market 2014-2018

By Infiniti Research Limited
"......tatic pancreatic order. The incidence and mortality rate of pancreatic cancer is higher in men than in women. SEER estimates that there were 46,420 new pancreatic cancer cases recorded in the US in 2014. It also estimated that 39,590 deaths occurred ......"
1-Oct-2014$2500

Waldenstrom Macroglobulinemia – Pipeline Review, H2 2014

By Global Markets Direct
"......arative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players invol......"
30-Sep-2014$2000

Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2014

By Global Markets Direct
"......oma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also r......"
30-Sep-2014$2000

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) – Pipeline Review, H2 2014

By Global Markets Direct
"......on the therapeutic development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administrati......"
30-Sep-2014$2000

Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H2 2014

By Global Markets Direct
"...... Carcinoma (HCC), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press release......"
30-Sep-2014$2000

Refractory Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2014

By Global Markets Direct
"......c Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and p......"
22-Sep-2014$2000

Hairy Cell Leukemia – Pipeline Review, H2 2014

By Global Markets Direct
"......ages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic develop......"
22-Sep-2014$2000

Anaplastic Thyroid Cancer – Pipeline Review, H2 2014

By Global Markets Direct
"......ysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the t......"
15-Sep-2014$2000

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 – Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

By GBI Research
"......cation. It gives an estimation of market size for 2013 along with forecasts until 2020 for the Asia-Pacific (APAC) region, which comprises Australia, China, India and Japan. It also covers disease epidemiology, treatment algorithms, treatment pattern......"
15-Sep-2014$4995

Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2014

By Global Markets Direct
"...... Recurrent Head And Neck Cancer Squamous Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updat......"
15-Sep-2014$2000
Live Chat
Live Chat by Comm100